— Know what they know.
Not Investment Advice

CHCT NYSE

Community Healthcare Trust Incorporated
1W: +3.9% 1M: +3.6% 3M: +7.2% YTD: +11.8% 1Y: +13.9% 3Y: -35.5% 5Y: -48.4%
$17.38
-0.34 (-1.92%)
 
Weekly Expected Move ±3.2%
$16 $16 $17 $17 $18
NYSE · Real Estate · REIT - Healthcare Facilities · Alpha Radar Strong Buy · Power 64 · $496.6M mcap · 25M float · 0.964% daily turnover · Short 45% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
48.8 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 4.0%  ·  5Y Avg: 2.1%
Cost Advantage
42
Intangibles
41
Switching Cost
67
Network Effect
44
Scale
45
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CHCT shows a Weak competitive edge (48.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 4.0% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$19
Avg Target
$19
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 8Sell: 1Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$18.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-19 Evercore ISI James Kammert $18 $17 -1 -1.0% $17.17
2026-01-20 Truist Financial $19 $20 +1 +17.4% $17.04
2025-08-13 Truist Financial Michael Lewis $23 $19 -4 +28.0% $14.85
2024-12-17 Truist Financial Michael Lewis $30 $23 -7 +22.0% $18.85
2024-10-31 Piper Sandler Alexander Goldfarb $18 $19 +1 +0.3% $18.94
2024-09-16 Evercore ISI Steve Sakwa $43 $18 -25 +3.6% $17.38
2024-09-09 Piper Sandler Alexander Goldfarb Initiated $18 +11.0% $16.22
2024-06-14 Truist Financial Michael Lewis $44 $30 -14 +29.1% $23.23
2022-09-27 Evercore ISI Initiated $43 +40.2% $30.66
2022-07-11 Truist Financial Initiated $44 +23.6% $35.59

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
May 22, 2026
DCF
4
ROE
2
ROA
3
D/E
2
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CHCT receives an overall rating of B-. Strongest factors: DCF (4/5). Areas of concern: ROE (2/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-13 B B-
2026-04-10 B- B
2026-02-18 C+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

55 Grade B
Profitability
46
Balance Sheet
25
Earnings Quality
65
Growth
59
Value
49
Momentum
88
Safety
15
Cash Flow
86
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CHCT scores highest in Momentum (88/100) and lowest in Safety (15/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.33
Distress Zone
Piotroski F-Score
7/9
Beneish M-Score
-2.85
Unlikely Manipulator
Ohlson O-Score
-7.11
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB
Score: 42.4/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 9.20x
Accruals: -5.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CHCT scores 0.33, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CHCT scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CHCT's score of -2.85 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CHCT's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CHCT receives an estimated rating of BB (score: 42.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CHCT's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
77.42x
PEG
0.55x
P/S
4.06x
P/B
1.11x
P/FCF
7.73x
P/OCF
7.69x
EV/EBITDA
12.24x
EV/Revenue
7.86x
EV/EBIT
27.38x
EV/FCF
17.34x
Earnings Yield
1.41%
FCF Yield
12.93%
Shareholder Yield
12.71%
Graham Number
$8.96
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 77.4x earnings, CHCT is priced for high growth expectations. Graham's intrinsic value formula yields $8.96 per share, 94% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.996
NI / EBT
×
Interest Burden
0.173
EBT / EBIT
×
EBIT Margin
0.287
EBIT / Rev
×
Asset Turnover
0.123
Rev / Assets
×
Equity Multiplier
2.191
Assets / Equity
=
ROE
1.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CHCT's ROE of 1.3% is driven by a balanced combination of operating margin, asset efficiency, and leverage. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$1.91
Price/Value
8.33x
Margin of Safety
-732.77%
Premium
732.77%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CHCT's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. CHCT trades at a 733% premium to its adjusted intrinsic value of $1.91, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 77.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$17.37
Median 1Y
$15.45
5th Pctile
$7.98
95th Pctile
$29.82
Ann. Volatility
38.7%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Timothy G. Wallace
Former Chief Executive Officer and President
$794,200 $2,820,373 $4,540,328
David H. Dupuy
Chief Executive Officer and Chief Financial Officer
$487,200 $1,730,216 $2,785,183
Leigh Ann Stach
Chief Accounting Officer and Executive Vice President
$410,500 $1,457,816 $2,342,141
Timothy L. Meyer
Executive Vice President - Asset Management
$312,400 $1,109,474 $1,785,445

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,540,328
Avg Employee Cost (SGA/emp): $717,000
Employees: 35

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
35
-2.8% YoY
Revenue / Employee
$3,462,714
Rev: $121,195,000
Profit / Employee
$145,771
NI: $5,102,000
SGA / Employee
$717,000
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 5.5% 5.5% 5.0% 5.1% 5.1% 5.1% 4.6% 2.0% 2.2% 1.7% 1.5% 3.6% 0.3% -0.1% -0.6% -1.1% -1.5% -1.5% 1.1% 1.3% 1.34%
ROA 3.5% 3.5% 3.2% 3.2% 3.2% 3.2% 2.7% 1.2% 1.3% 1.0% 0.8% 2.0% 0.1% -0.0% -0.3% -0.5% -0.8% -0.8% 0.5% 0.6% 0.61%
ROIC 4.7% 4.9% 4.5% 4.6% 4.6% 4.6% 4.0% 2.7% 2.9% 2.8% 2.6% 3.9% 2.0% 1.8% 1.7% 1.6% 1.9% 2.9% 3.8% 4.0% 3.96%
ROCE 4.9% 5.0% 4.5% 4.6% 4.6% 4.7% 3.9% 2.7% 2.9% 2.9% 2.8% 4.0% 2.4% 2.3% 2.7% 2.6% 2.4% 2.5% 3.4% 3.5% 3.55%
Gross Margin 83.1% 82.6% 84.8% 82.6% 83.1% 82.6% 83.6% 82.1% 82.8% 81.0% 80.8% 45.3% 79.7% 42.9% 81.3% 79.7% 80.8% 80.8% 10.7% 79.8% 79.80%
Operating Margin 37.1% 35.2% 37.5% 34.6% 34.5% 35.2% 34.4% -10.7% 36.0% 29.4% 32.8% 29.7% -16.7% 26.3% 28.0% 26.4% -2.4% 65.6% 30.2% 29.8% 29.79%
Net Margin 25.2% 23.0% 26.3% 23.5% 23.2% 22.9% 20.7% -25.5% 23.6% 12.2% 15.7% 12.5% -37.9% 5.9% 6.3% 5.3% -43.2% 5.3% 46.6% 8.1% 8.08%
EBITDA Margin 70.3% 68.8% 73.1% 68.5% 69.2% 67.4% 67.2% 23.5% 72.7% 68.4% 68.0% 65.5% 23.7% 64.0% 66.0% 62.8% 17.6% 63.7% 1.1% 63.6% 63.59%
FCF Margin 54.8% 53.8% 54.2% 53.1% 53.1% 52.8% 51.1% 45.3% 43.3% 43.4% 37.6% 36.0% 33.1% 26.4% 29.6% 31.3% 30.9% 31.4% 46.7% 45.3% 45.34%
OCF Margin 63.1% 61.7% 62.2% 61.8% 61.4% 62.6% 61.7% 57.8% 57.2% 57.3% 54.4% 53.3% 53.5% 49.7% 50.9% 52.0% 48.9% 47.4% 46.7% 45.6% 45.57%
ROE 3Y Avg snapshot only 1.29%
ROE 5Y Avg snapshot only 2.14%
ROA 3Y Avg snapshot only 0.67%
ROIC 3Y Avg snapshot only 1.98%
ROIC Economic snapshot only 3.96%
Cash ROA snapshot only 5.63%
Cash ROIC snapshot only 5.79%
CROIC snapshot only 5.77%
NOPAT Margin snapshot only 31.14%
Pretax Margin snapshot only 4.97%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 20.51%
SBC / Revenue snapshot only 8.42%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 37.24 35.97 36.64 32.75 28.61 25.80 29.96 72.53 62.13 72.60 73.32 31.70 404.43 -942.07 -143.35 -84.29 -56.65 -53.23 86.44 70.79 77.423
P/S Ratio 9.57 8.89 9.10 8.02 6.87 6.18 6.75 6.85 6.24 5.58 5.01 5.04 4.57 3.63 3.94 3.80 3.54 3.34 3.65 3.50 4.058
P/B Ratio 1.86 1.81 1.78 1.61 1.40 1.28 1.33 1.40 1.32 1.23 1.10 1.13 1.02 0.82 0.96 0.93 0.88 0.84 1.03 1.00 1.113
P/FCF 17.48 16.51 16.77 15.11 12.93 11.70 13.22 15.11 14.42 12.85 13.34 14.02 13.81 13.77 13.32 12.16 11.48 10.65 7.81 7.73 7.731
P/OCF 15.17 14.42 14.63 12.98 11.18 9.87 10.94 11.85 10.92 9.74 9.21 9.46 8.55 7.31 7.74 7.30 7.25 7.05 7.81 7.69 7.692
EV/EBITDA 17.11 16.13 17.11 15.54 13.89 12.91 15.13 18.32 16.60 15.08 14.75 12.53 14.32 12.85 14.71 14.58 14.51 14.05 12.58 12.24 12.240
EV/Revenue 12.09 11.30 12.05 10.90 9.71 8.97 10.29 10.26 9.53 8.75 8.63 8.60 8.14 7.17 8.13 7.97 7.65 7.42 8.05 7.86 7.859
EV/EBIT 32.89 31.24 32.92 29.99 27.14 25.10 29.64 45.43 39.60 38.11 37.66 26.37 41.88 38.33 46.35 47.55 50.20 46.72 28.92 27.38 27.381
EV/FCF 22.09 20.99 22.21 20.54 18.27 16.99 20.15 22.64 22.02 20.16 22.98 23.90 24.57 27.17 27.50 25.49 24.79 23.62 17.26 17.34 17.336
Earnings Yield 2.7% 2.8% 2.7% 3.1% 3.5% 3.9% 3.3% 1.4% 1.6% 1.4% 1.4% 3.2% 0.2% -0.1% -0.7% -1.2% -1.8% -1.9% 1.2% 1.4% 1.41%
FCF Yield 5.7% 6.1% 6.0% 6.6% 7.7% 8.5% 7.6% 6.6% 6.9% 7.8% 7.5% 7.1% 7.2% 7.3% 7.5% 8.2% 8.7% 9.4% 12.8% 12.9% 12.93%
PEG Ratio snapshot only 0.549
EV/OCF snapshot only 17.248
EV/Gross Profit snapshot only 12.516
Acquirers Multiple snapshot only 25.146
Shareholder Yield snapshot only 12.71%
Graham Number snapshot only $8.96
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.77 0.77 1.98 1.98 1.98 1.98 4.39 4.39 4.39 4.39 5.74 5.74 5.74 5.74 0.25 0.25 0.25 0.25 205.23 205.23 205.232
Quick Ratio 0.77 0.77 1.98 1.98 1.98 1.98 4.39 4.39 4.39 4.39 5.74 5.74 5.74 5.74 0.25 0.25 0.25 0.25 205.23 205.23 205.232
Debt/Equity 0.50 0.50 0.58 0.58 0.58 0.58 0.72 0.72 0.72 0.72 0.80 0.80 0.80 0.80 1.03 1.03 1.03 1.03 1.25 1.25 1.249
Net Debt/Equity 0.49 0.49 0.58 0.58 0.58 0.58 0.70 0.70 0.70 0.70 0.80 0.80 0.80 0.80 1.02 1.02 1.02 1.02 1.24 1.24 1.241
Debt/Assets 0.32 0.32 0.36 0.36 0.36 0.36 0.41 0.41 0.41 0.41 0.44 0.44 0.44 0.44 0.49 0.49 0.49 0.49 0.54 0.54 0.541
Debt/EBITDA 3.61 3.48 4.23 4.14 4.10 4.06 5.37 6.29 5.91 5.64 6.24 5.23 6.32 6.39 7.65 7.69 7.87 7.79 6.93 6.82 6.824
Net Debt/EBITDA 3.57 3.44 4.19 4.11 4.06 4.02 5.20 6.09 5.73 5.46 6.19 5.18 6.27 6.34 7.59 7.62 7.80 7.72 6.88 6.78 6.781
Interest Coverage 3.35 3.20 3.14 3.08 3.07 3.05 2.86 1.73 1.73 1.54 1.46 2.00 1.08 0.97 0.86 0.78 0.70 0.72 1.18 1.21 1.211
Equity Multiplier 1.55 1.55 1.63 1.63 1.63 1.63 1.76 1.76 1.76 1.76 1.84 1.84 1.84 1.84 2.09 2.09 2.09 2.09 2.31 2.31 2.307
Cash Ratio snapshot only 16.869
Debt Service Coverage snapshot only 2.710
Cash to Debt snapshot only 0.006
FCF to Debt snapshot only 0.103
Defensive Interval snapshot only 384.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.14 0.14 0.13 0.13 0.13 0.13 0.12 0.12 0.13 0.13 0.12 0.13 0.13 0.13 0.12 0.12 0.12 0.12 0.12 0.12 0.123
Inventory Turnover
Receivables Turnover 8.96 9.38 7.41 7.58 7.69 7.82 6.07 6.30 6.53 6.78 5.47 5.58 5.56 5.61 4.86 4.89 4.95 5.00 3.91 3.96 3.956
Payables Turnover 3.44 5.30 5.43 7.34 7.32 5.66 5.66 3.84 6.06 6.10 6.101
DSO 41 39 49 48 47 47 60 58 56 54 67 65 66 65 75 75 74 73 93 92 92.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 0 0 0 0 0 0 0 0 0 0 106 69 67 50 50 64 64 95 60 60 59.8 days
Cash Conversion Cycle 41 39 49 48 47 47 60 58 56 54 -39 -3 -2 15 25 10 9 -22 33 32 32.4 days
Cash Velocity snapshot only 36.637
Capital Intensity snapshot only 8.096
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 20.6% 20.8% 19.7% 17.1% 12.5% 9.3% 7.8% 9.4% 11.8% 14.1% 15.5% 13.4% 9.1% 6.0% 2.6% 1.3% 3.0% 3.2% 4.4% 5.0% 5.01%
Net Income 59.2% 34.7% 17.9% 11.9% 5.1% 5.9% -2.1% -57.8% -53.2% -63.4% -65.0% 91.2% -87.7% -1.1% -1.4% -1.3% -6.7% -15.8% 2.6% 2.2% 2.15%
EPS 46.0% 25.5% 7.9% 8.3% 3.4% 5.4% -3.0% -59.0% -56.0% -66.1% -67.9% 76.1% -88.4% -1.1% -1.4% -1.3% -6.6% -15.6% 2.6% 2.1% 2.14%
FCF 27.3% 19.6% 18.7% 11.2% 9.2% 7.2% 1.6% -6.6% -8.9% -6.2% -15.0% -10.0% -16.6% -35.6% -19.3% -11.9% -4.0% 22.7% 64.8% 52.3% 52.26%
EBITDA 26.2% 23.6% 18.9% 16.3% 11.3% 8.4% 4.3% -12.7% -8.1% -4.7% -0.6% 38.9% 8.0% 1.9% -3.1% -19.3% -4.4% -2.4% 20.9% 23.4% 23.36%
Op. Income 39.0% 18.3% 17.8% 14.7% 9.1% 7.7% 3.0% -31.8% -26.4% -28.4% -25.9% 61.0% -9.9% -11.6% -19.9% -47.4% 5.0% 66.2% 82.9% 97.9% 97.86%
OCF Growth snapshot only -8.06%
Asset Growth snapshot only -0.18%
Equity Growth snapshot only -9.79%
Debt Growth snapshot only 9.43%
Shares Change snapshot only 0.97%
Dividend Growth snapshot only 3.45%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 23.6% 22.7% 23.0% 22.3% 21.4% 19.4% 17.1% 15.8% 14.9% 14.6% 14.2% 13.3% 11.1% 9.7% 8.5% 7.9% 7.9% 7.7% 7.4% 6.5% 6.48%
Revenue 5Y 39.3% 31.4% 29.2% 27.0% 25.0% 23.1% 21.2% 20.0% 18.9% 18.1% 18.3% 17.8% 16.9% 15.5% 13.7% 12.3% 11.2% 10.5% 9.8% 9.1% 9.11%
EPS 3Y 36.3% 27.6% 56.5% 63.2% 68.8% 62.3% 29.6% -9.4% -12.7% -23.5% -30.5% -7.9% -62.5% -41.0% -17.2% -17.18%
EPS 5Y 71.9% 45.4% 34.9% 28.5% 28.7% 39.4% 31.3% 9.2% 2.9% -5.8% 3.6% 25.7% -24.4% -26.5% -24.1% -24.07%
Net Income 3Y 49.6% 40.2% 72.2% 78.7% 83.9% 74.9% 38.0% -4.6% -7.8% -19.5% -26.1% -3.4% -60.8% -38.6% -14.1% -14.14%
Net Income 5Y 95.9% 64.3% 52.6% 45.2% 45.4% 50.2% 44.4% 16.5% 10.5% 1.4% 11.9% 35.7% -18.6% -23.2% -21.5% -21.47%
EBITDA 3Y 25.0% 23.6% 30.2% 30.4% 29.3% 26.4% 18.7% 9.2% 8.9% 8.5% 7.2% 12.2% 3.3% 1.7% 0.1% -0.7% -1.8% -1.8% 5.2% 11.4% 11.44%
EBITDA 5Y 37.8% 30.5% 28.2% 25.9% 25.8% 23.8% 21.5% 15.5% 14.9% 14.3% 18.0% 21.9% 16.5% 14.4% 10.0% 7.9% 5.9% 4.9% 7.6% 7.0% 7.05%
Gross Profit 3Y 25.9% 24.7% 24.9% 24.5% 23.6% 21.5% 18.6% 16.7% 15.4% 14.8% 14.1% 8.5% 6.0% -0.4% -1.6% 2.2% 2.4% 6.5% -2.3% -2.9% -2.91%
Gross Profit 5Y 40.7% 32.1% 29.8% 27.8% 26.2% 24.9% 23.1% 21.7% 20.3% 19.2% 19.0% 15.8% 14.6% 10.0% 8.1% 9.3% 8.2% 10.1% 4.0% 3.4% 3.36%
Op. Income 3Y 40.9% 34.6% 34.8% 41.0% 48.2% 53.9% 40.8% 10.3% 3.7% -3.0% -3.5% 8.0% -10.2% -12.0% -15.1% -16.7% -11.4% 1.7% 2.8% 18.8% 18.78%
Op. Income 5Y 82.6% 62.9% 53.4% 47.0% 41.7% 40.4% 35.6% 20.9% 17.6% 13.5% 13.3% 25.2% 16.7% 18.2% 10.6% 2.6% 1.1% 6.0% 5.7% 5.6% 5.57%
FCF 3Y 27.7% 33.3% 35.2% 30.6% 29.2% 24.9% 21.3% 14.2% 8.2% 6.4% 0.8% -2.2% -6.0% -13.5% -11.3% -9.5% -10.0% -9.5% 4.2% 6.5% 6.48%
FCF 5Y 16.9% 14.0% 29.8% 25.7% 26.2% 22.2% 18.9% 16.9% 15.7% 19.0% 16.4% 13.4% 10.4% 3.3% 4.1% 3.4% 0.3% -1.0% 6.4% 4.6% 4.63%
OCF 3Y 26.0% 29.7% 32.1% 30.4% 30.8% 26.3% 23.0% 18.4% 13.0% 11.6% 8.3% 5.9% 5.2% 2.2% 1.5% 1.9% -0.0% -1.9% -2.2% -1.6% -1.63%
OCF 5Y 44.3% 34.4% 30.4% 27.6% 28.0% 25.2% 22.2% 20.0% 17.9% 20.4% 20.2% 18.9% 18.9% 14.1% 12.7% 11.4% 6.7% 4.7% 3.1% 1.6% 1.56%
Assets 3Y 20.1% 20.1% 20.9% 20.9% 20.9% 20.9% 15.9% 15.9% 15.9% 15.9% 12.3% 12.3% 12.3% 12.3% 9.6% 9.6% 9.6% 9.6% 4.2% 4.2% 4.17%
Assets 5Y 36.2% 36.2% 24.6% 24.6% 24.6% 24.6% 17.8% 17.8% 17.8% 17.8% 17.3% 17.3% 17.3% 17.3% 12.0% 12.0% 12.0% 12.0% 8.2% 8.2% 8.19%
Equity 3Y 14.9% 14.9% 19.4% 19.4% 19.4% 19.4% 12.0% 12.0% 12.0% 12.0% 6.1% 6.1% 6.1% 6.1% 1.0% 1.0% 1.0% 1.0% -4.7% -4.7% -4.75%
Book Value 3Y 4.8% 4.5% 8.4% 9.0% 9.6% 10.7% 5.2% 6.4% 6.0% 6.4% -0.3% 1.2% 1.5% 1.7% -3.1% -3.2% -3.2% -3.4% -8.5% -8.1% -8.11%
Dividend 3Y -4.2% -5.0% -5.8% -5.8% -5.9% -5.4% -4.6% -3.6% -3.7% -3.0% -3.6% -1.9% -1.6% -1.5% -1.7% -2.1% -2.4% -2.9% -2.8% -2.4% -2.44%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.99 0.99 1.00 1.00 0.99 0.99 0.99 1.00 1.00 1.00 0.99 0.99 0.99 0.98 0.97 0.96 0.97 0.96 0.95 0.94 0.943
Earnings Stability 0.80 0.81 0.87 0.87 0.86 0.87 0.90 0.38 0.35 0.19 0.16 0.26 0.01 0.06 0.23 0.28 0.66 0.74 0.67 0.54 0.544
Margin Stability 0.98 0.98 0.98 0.98 0.98 0.97 0.97 0.97 0.97 0.98 0.98 0.94 0.94 0.88 0.88 0.92 0.92 0.88 0.85 0.89 0.886
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.86 0.93 0.95 0.98 0.98 0.99 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.20 0.20 0.200
Earnings Smoothness 0.54 0.70 0.84 0.89 0.95 0.94 0.98 0.19 0.28 0.07 0.04 0.37 0.00
ROE Trend 0.02 0.02 0.01 0.01 0.00 0.00 -0.00 -0.03 -0.03 -0.03 -0.03 0.00 -0.03 -0.03 -0.04 -0.04 -0.03 -0.02 0.01 0.00 0.002
Gross Margin Trend 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.00 -0.00 -0.01 -0.01 -0.11 -0.11 -0.21 -0.20 -0.07 -0.06 0.09 -0.09 -0.09 -0.087
FCF Margin Trend 0.07 0.04 0.04 0.02 -0.00 -0.01 -0.03 -0.09 -0.11 -0.10 -0.15 -0.13 -0.15 -0.22 -0.15 -0.09 -0.07 -0.04 0.13 0.12 0.117
Sustainable Growth Rate -4.9% -5.1% -4.5% -4.6% -4.7% -4.7% -4.7% -7.4% -7.4% -8.0% -8.0% -6.1% -9.7% -10.7% -10.6% -10.61%
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 2.46 2.49 2.51 2.52 2.56 2.61 2.74 6.12 5.69 7.45 7.96 3.35 47.33 -128.94 -18.51 -11.54 -7.82 -7.55 11.06 9.20 9.203
FCF/OCF 0.87 0.87 0.87 0.86 0.86 0.84 0.83 0.78 0.76 0.76 0.69 0.67 0.62 0.53 0.58 0.60 0.63 0.66 1.00 0.99 0.995
FCF/Net Income snapshot only 9.156
OCF/EBITDA snapshot only 0.710
CapEx/Revenue 8.4% 7.8% 8.0% 8.7% 8.3% 9.8% 10.6% 12.5% 13.9% 13.9% 16.8% 17.4% 20.4% 23.4% 21.3% 20.8% 18.0% 16.1% 0.0% 0.2% 0.23%
CapEx/Depreciation snapshot only 0.007
Accruals Ratio -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.06 -0.06 -0.07 -0.06 -0.05 -0.07 -0.06 -0.06 -0.07 -0.07 -0.07 -0.05 -0.05 -0.050
Sloan Accruals snapshot only 0.173
Cash Flow Adequacy snapshot only 1.026
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 5.1% 5.3% 5.1% 5.8% 6.8% 7.5% 6.7% 6.5% 7.0% 7.7% 8.5% 8.5% 9.5% 12.1% 11.3% 11.8% 12.6% 13.4% 12.2% 12.6% 10.96%
Dividend/Share $1.74 $1.77 $1.80 $1.83 $1.85 $1.87 $1.87 $1.86 $1.83 $1.84 $1.85 $1.87 $1.89 $1.91 $1.94 $1.96 $1.97 $1.98 $2.00 $2.00 $1.91
Payout Ratio 1.9% 1.9% 1.9% 1.9% 1.9% 1.9% 2.0% 4.7% 4.4% 5.6% 6.2% 2.7% 38.6% 10.5% 8.9% 8.92%
FCF Payout Ratio 88.5% 88.2% 86.3% 87.6% 87.3% 87.3% 89.1% 98.3% 1.0% 99.1% 1.1% 1.2% 1.3% 1.7% 1.5% 1.4% 1.4% 1.4% 95.1% 97.5% 97.48%
Total Payout Ratio 1.9% 1.9% 1.9% 1.9% 1.9% 1.9% 2.0% 4.7% 4.4% 5.6% 6.2% 2.7% 38.6% 10.5% 9.0% 8.99%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.21 0.19 0.17 0.16 0.15 0.14 0.12 0.11 0.12 0.14 0.17 0.17 0.18 0.21 0.19 0.18 0.18 0.18 0.16 0.16 0.161
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.5% 0.4% 0.0% 0.1% 0.10%
Net Buyback Yield -9.9% -7.8% -4.7% -2.5% -1.0% -0.0% -3.1% -4.1% -5.7% -9.1% -7.8% -6.3% -6.6% -4.0% -1.6% -1.4% 0.5% 0.4% 0.0% 0.1% 0.10%
Total Shareholder Return -4.8% -2.5% 0.5% 3.3% 5.7% 7.5% 3.6% 2.4% 1.3% -1.4% 0.7% 2.2% 2.9% 8.2% 9.7% 10.4% 13.1% 13.8% 12.2% 12.7% 12.71%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.99 0.99 0.99 1.00 1.00 1.00 1.00 0.99 0.99 0.96 0.96 0.99 0.85 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.996
Interest Burden (EBT/EBIT) 0.70 0.69 0.68 0.68 0.67 0.67 0.65 0.42 0.42 0.35 0.31 0.50 0.07 -0.02 -0.16 -0.27 -0.41 -0.40 0.15 0.17 0.173
EBIT Margin 0.37 0.36 0.37 0.36 0.36 0.36 0.35 0.23 0.24 0.23 0.23 0.33 0.19 0.19 0.18 0.17 0.15 0.16 0.28 0.29 0.287
Asset Turnover 0.14 0.14 0.13 0.13 0.13 0.13 0.12 0.12 0.13 0.13 0.12 0.13 0.13 0.13 0.12 0.12 0.12 0.12 0.12 0.12 0.123
Equity Multiplier 1.57 1.57 1.59 1.59 1.59 1.59 1.70 1.70 1.70 1.70 1.80 1.80 1.80 1.80 1.96 1.96 1.96 1.96 2.19 2.19 2.191
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.93 $0.92 $0.95 $0.96 $0.96 $0.97 $0.93 $0.40 $0.42 $0.33 $0.30 $0.70 $0.05 $-0.02 $-0.12 $-0.20 $-0.28 $-0.28 $0.19 $0.22 $0.22
Book Value/Share $18.53 $18.32 $19.61 $19.61 $19.60 $19.59 $20.89 $20.51 $19.82 $19.47 $19.76 $19.52 $19.38 $19.25 $17.84 $17.80 $17.76 $17.67 $15.99 $15.91 $15.61
Tangible Book/Share $18.51 $18.29 $19.58 $19.58 $19.57 $19.57 $20.79 $20.41 $19.73 $19.38 $19.65 $19.42 $19.28 $19.15 $17.77 $17.73 $17.69 $17.60 $-23.02 $-22.91 $-22.91
Revenue/Share $3.60 $3.73 $3.84 $3.93 $3.99 $4.05 $4.11 $4.18 $4.19 $4.27 $4.34 $4.37 $4.33 $4.34 $4.34 $4.36 $4.41 $4.43 $4.50 $4.53 $4.53
FCF/Share $1.97 $2.01 $2.08 $2.09 $2.12 $2.14 $2.10 $1.90 $1.82 $1.86 $1.63 $1.57 $1.43 $1.14 $1.28 $1.36 $1.36 $1.39 $2.10 $2.06 $2.06
OCF/Share $2.27 $2.30 $2.39 $2.43 $2.45 $2.54 $2.53 $2.42 $2.40 $2.45 $2.36 $2.33 $2.32 $2.16 $2.21 $2.27 $2.15 $2.10 $2.10 $2.07 $2.07
Cash/Share $0.11 $0.11 $0.10 $0.10 $0.10 $0.10 $0.47 $0.46 $0.45 $0.44 $0.13 $0.13 $0.13 $0.13 $0.16 $0.16 $0.16 $0.16 $0.12 $0.12 $0.10
EBITDA/Share $2.55 $2.61 $2.71 $2.76 $2.79 $2.82 $2.79 $2.34 $2.41 $2.48 $2.54 $3.00 $2.46 $2.42 $2.40 $2.38 $2.32 $2.34 $2.88 $2.91 $2.91
Debt/Share $9.19 $9.08 $11.43 $11.43 $11.43 $11.42 $15.01 $14.74 $14.25 $13.99 $15.87 $15.68 $15.57 $15.46 $18.36 $18.33 $18.28 $18.19 $19.96 $19.87 $19.87
Net Debt/Share $9.08 $8.98 $11.33 $11.33 $11.33 $11.32 $14.54 $14.27 $13.80 $13.55 $15.73 $15.54 $15.44 $15.33 $18.20 $18.16 $18.12 $18.03 $19.84 $19.74 $19.74
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.331
Altman Z-Prime snapshot only 0.337
Piotroski F-Score 7 7 8 8 7 6 5 6 6 6 6 7 6 5 5 4 5 5 6 7 7
Beneish M-Score -2.73 -2.75 -2.26 -2.23 -2.25 -2.25 -2.46 -3.04 -2.47 -2.48 -3.00 -2.45 -3.12 -2.67 12.51 12.30 12.56 12.33 0.44 -2.85 -2.854
Ohlson O-Score snapshot only -7.109
Net-Net WC snapshot only $-19.29
EVA snapshot only $-58122833.02
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 59.85 61.01 63.13 63.68 54.47 57.49 54.94 53.27 53.93 55.07 42.87 48.66 41.41 39.67 17.35 17.75 16.79 17.66 39.95 42.38 42.382
Credit Grade snapshot only 12
Credit Trend snapshot only 24.631
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 57
Sector Credit Rank snapshot only 47

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms